Cargando…

Neurological Complications in Eosinophilic Granulomatosis with Polyangiitis (EGPA): The Roles of History and Physical Examinations in the Diagnosis of EGPA

OBJECTIVE: To investigate the clinical symptoms, the physical and neurological findings, and the clinical course of neurological complications in eosinophilic granulomatosis with polyangiitis (EGPA). METHODS: A retrospective chart review of EGPA cases managed by two referral hospitals was performed,...

Descripción completa

Detalles Bibliográficos
Autores principales: Oiwa, Hiroshi, Mokuda, Sho, Matsubara, Tomoyasu, Funaki, Masamoto, Takeda, Ikuko, Yamawaki, Takemori, Kumagai, Kazuhiko, Sugiyama, Eiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726955/
https://www.ncbi.nlm.nih.gov/pubmed/28924115
http://dx.doi.org/10.2169/internalmedicine.8457-16
_version_ 1783285776601055232
author Oiwa, Hiroshi
Mokuda, Sho
Matsubara, Tomoyasu
Funaki, Masamoto
Takeda, Ikuko
Yamawaki, Takemori
Kumagai, Kazuhiko
Sugiyama, Eiji
author_facet Oiwa, Hiroshi
Mokuda, Sho
Matsubara, Tomoyasu
Funaki, Masamoto
Takeda, Ikuko
Yamawaki, Takemori
Kumagai, Kazuhiko
Sugiyama, Eiji
author_sort Oiwa, Hiroshi
collection PubMed
description OBJECTIVE: To investigate the clinical symptoms, the physical and neurological findings, and the clinical course of neurological complications in eosinophilic granulomatosis with polyangiitis (EGPA). METHODS: A retrospective chart review of EGPA cases managed by two referral hospitals was performed, with a focus on the neurological findings. The study analyzed the symptoms at the onset of EGPA and investigated their chronological relationship. The patient delay (the delay between the onset of symptoms and the initial consultation), and the physician delay (the delay from consultation to the initiation of therapy) were determined and compared. The involved nerves were identified thorough a neurological examination. The cases with central nervous system (CNS) involvement were described. RESULTS: The average duration of symptoms prior to the initiating of therapy for sensory disturbances, motor deficits, rash, edema, and fever was 23, 5, 21, 18, and 24 days, respectively. Among the EGPA-specific symptoms, sensory disturbance was often the first symptom (63%), and was usually followed by the appearance of rash within four days (63%). The average physician delay (32.9±38.3 days) was significantly longer than the average patient delay (7.9±7.8 days; p=0.010). Reduced touch sensation in the superficial peroneal area, and weakness of dorsal flexion of the first toe secondary to deep peroneal nerve involvement, were highly sensitive for identifying the presence of peripheral nerve involvement in our series of patients with EGPA. Two cases, with CNS involvement, had multiple skin lesions over their hands and feet (Janeway lesions). CONCLUSION: Japanese physicians are not always familiar with EGPA. It is important for us to consider this disease, when an asthmatic patient complains about the new onset of an abnormal sensation in the distal lower extremities, which is followed several days later by rash.
format Online
Article
Text
id pubmed-5726955
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-57269552017-12-13 Neurological Complications in Eosinophilic Granulomatosis with Polyangiitis (EGPA): The Roles of History and Physical Examinations in the Diagnosis of EGPA Oiwa, Hiroshi Mokuda, Sho Matsubara, Tomoyasu Funaki, Masamoto Takeda, Ikuko Yamawaki, Takemori Kumagai, Kazuhiko Sugiyama, Eiji Intern Med Original Article OBJECTIVE: To investigate the clinical symptoms, the physical and neurological findings, and the clinical course of neurological complications in eosinophilic granulomatosis with polyangiitis (EGPA). METHODS: A retrospective chart review of EGPA cases managed by two referral hospitals was performed, with a focus on the neurological findings. The study analyzed the symptoms at the onset of EGPA and investigated their chronological relationship. The patient delay (the delay between the onset of symptoms and the initial consultation), and the physician delay (the delay from consultation to the initiation of therapy) were determined and compared. The involved nerves were identified thorough a neurological examination. The cases with central nervous system (CNS) involvement were described. RESULTS: The average duration of symptoms prior to the initiating of therapy for sensory disturbances, motor deficits, rash, edema, and fever was 23, 5, 21, 18, and 24 days, respectively. Among the EGPA-specific symptoms, sensory disturbance was often the first symptom (63%), and was usually followed by the appearance of rash within four days (63%). The average physician delay (32.9±38.3 days) was significantly longer than the average patient delay (7.9±7.8 days; p=0.010). Reduced touch sensation in the superficial peroneal area, and weakness of dorsal flexion of the first toe secondary to deep peroneal nerve involvement, were highly sensitive for identifying the presence of peripheral nerve involvement in our series of patients with EGPA. Two cases, with CNS involvement, had multiple skin lesions over their hands and feet (Janeway lesions). CONCLUSION: Japanese physicians are not always familiar with EGPA. It is important for us to consider this disease, when an asthmatic patient complains about the new onset of an abnormal sensation in the distal lower extremities, which is followed several days later by rash. The Japanese Society of Internal Medicine 2017-09-15 2017-11-15 /pmc/articles/PMC5726955/ /pubmed/28924115 http://dx.doi.org/10.2169/internalmedicine.8457-16 Text en Copyright © 2017 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Oiwa, Hiroshi
Mokuda, Sho
Matsubara, Tomoyasu
Funaki, Masamoto
Takeda, Ikuko
Yamawaki, Takemori
Kumagai, Kazuhiko
Sugiyama, Eiji
Neurological Complications in Eosinophilic Granulomatosis with Polyangiitis (EGPA): The Roles of History and Physical Examinations in the Diagnosis of EGPA
title Neurological Complications in Eosinophilic Granulomatosis with Polyangiitis (EGPA): The Roles of History and Physical Examinations in the Diagnosis of EGPA
title_full Neurological Complications in Eosinophilic Granulomatosis with Polyangiitis (EGPA): The Roles of History and Physical Examinations in the Diagnosis of EGPA
title_fullStr Neurological Complications in Eosinophilic Granulomatosis with Polyangiitis (EGPA): The Roles of History and Physical Examinations in the Diagnosis of EGPA
title_full_unstemmed Neurological Complications in Eosinophilic Granulomatosis with Polyangiitis (EGPA): The Roles of History and Physical Examinations in the Diagnosis of EGPA
title_short Neurological Complications in Eosinophilic Granulomatosis with Polyangiitis (EGPA): The Roles of History and Physical Examinations in the Diagnosis of EGPA
title_sort neurological complications in eosinophilic granulomatosis with polyangiitis (egpa): the roles of history and physical examinations in the diagnosis of egpa
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726955/
https://www.ncbi.nlm.nih.gov/pubmed/28924115
http://dx.doi.org/10.2169/internalmedicine.8457-16
work_keys_str_mv AT oiwahiroshi neurologicalcomplicationsineosinophilicgranulomatosiswithpolyangiitisegpatherolesofhistoryandphysicalexaminationsinthediagnosisofegpa
AT mokudasho neurologicalcomplicationsineosinophilicgranulomatosiswithpolyangiitisegpatherolesofhistoryandphysicalexaminationsinthediagnosisofegpa
AT matsubaratomoyasu neurologicalcomplicationsineosinophilicgranulomatosiswithpolyangiitisegpatherolesofhistoryandphysicalexaminationsinthediagnosisofegpa
AT funakimasamoto neurologicalcomplicationsineosinophilicgranulomatosiswithpolyangiitisegpatherolesofhistoryandphysicalexaminationsinthediagnosisofegpa
AT takedaikuko neurologicalcomplicationsineosinophilicgranulomatosiswithpolyangiitisegpatherolesofhistoryandphysicalexaminationsinthediagnosisofegpa
AT yamawakitakemori neurologicalcomplicationsineosinophilicgranulomatosiswithpolyangiitisegpatherolesofhistoryandphysicalexaminationsinthediagnosisofegpa
AT kumagaikazuhiko neurologicalcomplicationsineosinophilicgranulomatosiswithpolyangiitisegpatherolesofhistoryandphysicalexaminationsinthediagnosisofegpa
AT sugiyamaeiji neurologicalcomplicationsineosinophilicgranulomatosiswithpolyangiitisegpatherolesofhistoryandphysicalexaminationsinthediagnosisofegpa